Citicoline Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets/Capsules

Available Strengths: 250 mg, 500 mg, 1000 mg

Reference Brands: Cognizin®(US); Somazina®, NeurAxon®, Ceraxon®(EU)

Category: Antipsychotropic Drugs

Citicoline is a cognitive enhancer and neuroprotective agent used in stroke recovery and brain injury management. Available in oral (250–1000 mg) and injectable forms, it is marketed as Somazina (EU) and Cognizin (US). Pharmaceutical buyers source Citicoline for neurology-focused B2B demand and institutional supply chains. Citicoline is available in Oral Tablets/Capsules and strengths such as 250 mg, 500 mg, 1000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Citicoline is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Citicoline can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Citicoline, a neuroprotective agent, is widely used to enhance cognitive function and support recovery from stroke, traumatic brain injury, and neurodegenerative diseases. Available in oral and injectable forms, Citicoline is marketed in the EU under brands like Somazina and Ceraxon. In the US, it is available primarily as a dietary supplement under the brand Cognizin. Strengths range from 250 mg to 1000 mg for oral use and 100 mg/mL for injections. Citicoline boosts phospholipid synthesis and brain energy metabolism. Pharmacies, hospitals, and B2B pharmaceutical buyers rely on high-quality Citicoline formulations for neurological health support and clinical neurotherapy programs.